January 24, 2017 2:50 PM ET


Company Overview of Inflabloc Pharmaceuticals, Inc.

Key Executives for Inflabloc Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Willem F. O. Spiegel M.B.ANo RelationshipsActing Chief Financial Officer--
Claire A. Daugherty No RelationshipsDirector of Clinical Development--
John R. Gebhard Ph.d.No RelationshipsDirector of Research & Development--
Paul A. Litka M.d.No RelationshipsActing Medical Director67

Inflabloc Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Peter Friedli 17 RelationshipsFriedli Corporate Finance GmbH62
View All Board Members

Inflabloc Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Inflabloc Pharmaceuticals, Inc. CEO Compensation
Industry Average


DHG Pharmaceutical Joint Stock Company Announces Executive Changes
January 23, 2017 4:32 PM ET
BioPharmX Corporation Appoints Charles Greg Vontz as an Independent Director
January 23, 2017 2:15 PM ET
X4 Pharmaceuticals Appoints Dr. Sudha Parasuraman as Chief Medical Officer
January 23, 2017 1:30 PM ET
Aerie Pharmaceuticals Announces Appointment of Kristine Erickson as Vice President Clinical Research
January 23, 2017 11:30 AM ET
STADA Arzneimittel AG Appoints Barthold Piening as Full Member of the Executive Board, Effective July 1, 2017
January 23, 2017 9:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Inflabloc Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.